Standard Biotools Inc. (LAB) earnings
Quarterly results of Standard Biotools Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.
Latest quarter: Q3 FY2026
In Q3 FY2026 (ended September 30, 2026) Standard Biotools Inc. reported revenue of $19.4M (-0.9% on the same quarter a year earlier) and net income of $13.5M.
Diluted earnings per share were $0.03.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q3 FY2026 | $19.4M | -0.9% | $13.5M | $0.03 |
| Q2 FY2026 | $20.1M | -7.6% | -$26.8M | -$0.07 |
| Q1 FY2026 | $21.1M | +4.6% | $127.1M | $0.33 |
| Q4 FY2025 | $23.8M | +2,573.6% | $19.3M | - |
| Q3 FY2025 | $19.6M | - | -$34.7M | -$0.09 |
| Q2 FY2025 | $21.8M | - | -$33.5M | -$0.09 |
| Q1 FY2025 | $20.2M | - | -$26M | -$0.07 |
| Q4 FY2024 | $890K | - | -$34.1M | - |
Results filings
- Quarterly report 10-Q
- Quarterly report 10-Q
- Quarterly results 8-K
What were Standard Biotools Inc.'s latest quarterly results?
For Q3 FY2026, which ended September 30, 2026, Standard Biotools Inc. reported revenue of $19.4M and net income of $13.5M. The figures come from its filing with the SEC.
Is Standard Biotools Inc.'s revenue growing?
Revenue in Q3 FY2026 was $19.4M, down 0.9% from $19.6M in the same quarter a year earlier.
Get an email when LAB reports
Follow LAB and we email you its next results the day they are filed, with the numbers explained.